Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China.
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences (ICMS), University of Macau, Macau.
Eur J Pharm Sci. 2019 Apr 1;131:127-135. doi: 10.1016/j.ejps.2019.02.005. Epub 2019 Feb 5.
Molecular interactions between drug and polymeric carriers are believed to be the key for high drug loading and better physical stability of micro-particles. However, molecular interactions between drug and polymer are still difficult to investigate using only experimental tools. In this study, high-loaded glipizide (GLP)/hydroxypropyl methylcellulose acetate succinate (HPMCAS) (1/1 w/w) micro-particles were prepared using an in situ pH-dependent solubility method. Molecular interactions within the micro-particles were investigated by integrated experimental and modeling techniques. The dissolution rate of GLP/HPMCAS micro-particles was significantly better than those of solid dispersions and physical mixtures. Scanning electron microscopy images showed that the polymer inhibited GLP recrystallization. Experimental (FTIR spectroscopy, differential scanning calorimetry, powder X-ray diffraction and nuclear magnetic resonance spectroscopy) and molecular dynamics simulation revealed that hydrogen-bonding was the key to the properties of the micro-particles. Our research developed high drug-loading GLP/HPMCAS micro-particles and investigated the interactions between drug and polymer at the molecular level. This integrated approach could be practical methodology for future formulation design.
药物与聚合物载体之间的分子相互作用被认为是实现高载药量和更好的微颗粒物理稳定性的关键。然而,仅使用实验工具仍然难以研究药物与聚合物之间的分子相互作用。在这项研究中,使用原位 pH 依赖性溶解度法制备了高载药量格列吡嗪(GLP)/羟丙基甲基纤维素醋酸琥珀酸酯(HPMCAS)(1/1 w/w)微颗粒。通过综合实验和建模技术研究了微颗粒内的分子相互作用。GLP/HPMCAS 微颗粒的溶出速率明显优于固体分散体和物理混合物。扫描电子显微镜图像表明聚合物抑制了 GLP 的重结晶。实验(傅里叶变换红外光谱、差示扫描量热法、粉末 X 射线衍射和核磁共振波谱)和分子动力学模拟表明氢键是微颗粒性质的关键。我们的研究开发了高载药量 GLP/HPMCAS 微颗粒,并在分子水平上研究了药物与聚合物之间的相互作用。这种综合方法可能是未来制剂设计的实用方法。